Atopic Dermatitis Drug Gets FDA Approval

Article

Crisaborole ointment (Eucrisa) treats mild to moderate eczema in patients 2 years and older.

The FDA today approved Anacor Pharmaceuticals’ crisaborole ointment (Eucrisa) for the treatment of mild to moderate eczema in patients 2 years and older.

The drug, a phosphodiesterase 4 (PDE-4) inhibitor, is specifically indicated for the twice-daily treatment of atopic dermatitis, a common type of eczema in which patients develop red, itchy, swollen, and cracked skin.

The agency based its decision on the results of 2 placebo-controlled studies in which the safety and efficacy of Eucrisa were evaluated in a total of 1522 participants aged 2 to 79 years. The researchers found that patients who were treated with the drug achieved a greater response with clear or almost clear skin after 28 days compared with those who received placebo.

“Today’s approval provides another treatment option for patients dealing with mild to moderate atopic dermatitis,” said Amy Egan, MD, deputy director of the FDA’s Office of Drug Evaluation, in a press release.

The most common adverse event associated with the use of Eucrisa was application site pain, including burning or stinging. The FDA acknowledged that some trial participants also experienced hypersensitivity reactions, and warned that Eucrisa should not be used in patients with a history of such reactions to the drug’s active ingredient, crisaborole.

Related Videos
Pharmacist holding medicine box in pharmacy drugstore. | Image Credit: I Viewfinder - stock.adobe.com
Pharmacy Drugstore Checkout Cashier Counter | Image Credit: Gorodenkoff - stock.adobe.com
Medicine tablets on counting tray with counting spatula at pharmacy | Image Credit: sutlafk - stock.adobe.com
Capsules medicine and white medicine bottles on table | Image Credit: Satawat - stock.adobe.com
Human cell or Embryonic stem cell microscope background | Image Credit: Anusorn - stock.adobe.com
Concept of health care, pharmaceutical business, drug prices, pharmacy, medicine and economics | Image Credit: Oleg - stock.adobe.com
Biosimilar pharmaceutical drug bottle on blue background. | Image Credit: Carl - stock.adobe.com
Pharmaceutical manufacture background with glass bottles with clear liquid on automatic conveyor line. | Image Credit: wacomka - stock.adobe.com
Bottle and scattered pills on color background, top view | Image Credit: New Africa - stock.adobe.com
pharmacy | Image Credit: Diego Cervo - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.